Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include sometimes findings: Failure to thrive. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Seizure, Global developmental delay, Severe intellectual disability |
Head and neck |
ARFGEF2 encodes ARF guanine nucleotide exchange factor 2 (1,785 aa). Promotes guanine-nucleotide exchange on ARF1 and ARF3 and to a lower extent on ARF5 and ARF6. Promotes the activation of ARF1/ARF5/ARF6 through replacement of GDP with GTP. Highest expression in Thyroid (37.2 TPM) and Cells EBV-transformed lymphocytes (32.5 TPM).
Periventricular heterotopia with microcephaly, autosomal recessive is caused by mutations in the ARFGEF2 gene on chromosome 20.
ARFGEF2 is classified as a druggable target (Kinase category) with score 0.0.
Genetic testing for ARFGEF2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for periventricular heterotopia with microcephaly, autosomal recessive has been reported in the published literature.
No clinical trials have been registered for periventricular heterotopia with microcephaly, autosomal recessive.
19 publications have been identified in PubMed for periventricular heterotopia with microcephaly, autosomal recessive. Research spans Case Report / Case Series (32%), Review / Meta-Analysis (21%), and Basic Science / Preclinical (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 32% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:12 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
2
Progressive microcephaly, Microcephaly |
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Growth and development | 1 | Failure to thrive |
Research summaries |
4 |
21% |
Laboratory research | 3 | 16% |
Testing and diagnosis research | 2 | 11% |
Clinical study results | 2 | 11% |
Disease patterns and progression | 2 | 11% |
Liu X (2026). [PMID: 42255913](https://pubmed.ncbi.nlm.nih.gov/42255913/). *Front Pediatr*. [Case Report / Case Series]
Byerly K (2026). [PMID: 41972678](https://pubmed.ncbi.nlm.nih.gov/41972678/). *Cells*. [Basic Science / Preclinical]
Zhang Y (2026). [PMID: 41822039](https://pubmed.ncbi.nlm.nih.gov/41822039/). *Neurol Genet*. [Basic Science / Preclinical]
Ogasawara N (2026). [PMID: 41730622](https://pubmed.ncbi.nlm.nih.gov/41730622/). *Intern Med*. [Case Report / Case Series]
Stewart R (2026). [PMID: 40838347](https://pubmed.ncbi.nlm.nih.gov/40838347/). *Am J Med Genet A*. [Case Report / Case Series]
Parfyonov M (2026). [PMID: 41978567](https://pubmed.ncbi.nlm.nih.gov/41978567/). *Epilepsia*. [Diagnostic / Biomarker]
Hadi E (2026). [PMID: 41987549](https://pubmed.ncbi.nlm.nih.gov/41987549/). *Ultrasound Obstet Gynecol*. [Basic Science / Preclinical]
Winslow N (2025). [PMID: 40286393](https://pubmed.ncbi.nlm.nih.gov/40286393/). *J Clin Neurosci*. [Review / Meta-Analysis]
De Clerck L (2025). [PMID: 39679676](https://pubmed.ncbi.nlm.nih.gov/39679676/). *Epilepsia*. [Case Report / Case Series]
Hoshi K (2025). [PMID: 40862132](https://pubmed.ncbi.nlm.nih.gov/40862132/). *PCN Rep*. [Case Report / Case Series]